US Edition
A Groundbreaking Step: First NHS Patient Receives Hemgenix Gene Therapy for Hemophilia B – Patient Worthy
Summary by Patient Worthy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
A Groundbreaking Step: First NHS Patient Receives Hemgenix Gene Therapy for Hemophilia B – Patient Worthy
The treatment landscape for hemophilia B has taken a historic leap forward, as the first patient in the UK’s National Health Service (NHS) has received Hemgenix, a pioneering gene therapy developed by CSL Behring. As reported by PMLive, this moment marks not only a milestone for clinical practice in the UK, but also signals a […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
